During the past decade, Indiana Blood and Marrow Transplantation conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 15 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana Blood and Marrow Transplantation" #1 sponsor was "Pfizer" with 7 trials, followed by "Incyte Corporation" with 6 trials sponsored, "Cogent Biosciences, Inc." with 4 trials sponsored, "Genzyme, a Sanofi Company" with 4 trials sponsored and "Novartis Pharmaceuticals" with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana Blood and Marrow Transplantation" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 5 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "National Marrow Donor Program" with 4 trials as a collaborator and "Department of Health and Human Services" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Indiana Blood and Marrow Transplantation" are "Multiple Myeloma" (8 trials), "Acute Myeloid Leukemia" (6 trials), "Chronic Myeloid Leukemia" (5 trials), "Lymphoma" (4 trials) and "Lymphoma, Non-Hodgkin" (4 trials). Many other conditions were trialed in "Indiana Blood and Marrow Transplantation" in a lesser frequency.

Most popular intervention types in "Indiana Blood and Marrow Transplantation" are "Drug" (46 trials), "Biological" (13 trials), "Procedure" (4 trials), "Radiation" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bosutinib" (4 trials), "Imatinib" (3 trials), "Parsaclisib" (3 trials) and "ACTR087" (2 trials). Other intervention names were less common.

The vast majority of trials in "Indiana Blood and Marrow Transplantation" are 59 trials for "All" genders.

Currently, there are NaN active trials in "Indiana Blood and Marrow Transplantation". undefined are not yet recruiting, 4 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Indiana Blood and Marrow Transplantation, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana Blood and Marrow Transplantation, 10 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".